Story Brief

One may live for decades without needing treatment, while another may develop rapidly progressing disease. In a new study from Karolinska Institutet, published in the journal Blood Neoplasia , researchers map what distinguishes the two patient groups. Some of these differences are reflected in distinct groups of patients defined by expressing highly similar B-cell receptors, known as stereotyped subsets.

AI summaries can be wrong sometimes—always verify important details using the source article.